Although Byer claimed that it is rare for a patient with retinoschisis to experience visual field loss unless there is retinal detachment,'0 others' 19 reported that, if the patient is carefully examined, retinoschisis is almost always involved with an irreversible absolute visual field defect, and this field defect increases as the retinoschisis progresses.
The management of senile retinoschisis is controversial, and there are many conflicting reports on the indications for appropriate treatment of this disorder 7 8 10 12 14-17 [20] [21] [22] [23] [24] [25] [26] [27] Straatsma and Foos7 claimed that treatment should be given only in selected cases where the macula is threatened by the progression of the retinoschisis, or when retinal breaks in both layers predispose or cause rhegmatogenous retinal detachment. Byer'0 reached similar conclusions.
In the present study our indications for argon laser photocoagulation in retinoschisis are discussed and the results of our treatment reported.
Patients and methods
All the patients in the present study were treated at the Retinal Vascular Service at the Beilinson Medical Center during 1975-9. Fifty-seven eyes of49 patients, 24 men and 25 women, aged between 52 to 77 years, were treated by argon laser photocoagulation. All the treated eyes had the clinical appearance of senile retinoschisis, either reticular or typical. However, sometimes it was difficult to classify them to fit these criteria, as they had clinical features of both types of retinoschisis. 381
The argon laser treatment was performed from a few weeks to All the treated eyes had the argon laser photocoagulation for one to 3 sessions, in a similar mode to that described by l'Esperance23 and by Zweng and Little. 24 The treatment was carried out with a power of 500-2000 ,uW, time duration of 0-10-0-50 s and with spot size of 200-1000 ,uW, depending on the proximity to the macula and the presence of pigmentation under the split retina. We aimed at achieving strong-intensity applications. The limitation posterior to the schisis ordinarly included a zone of about 2-3 mm of flat retina, unless the proximity to the macula allowed only a narrower zone of demarcation (3 eyes). In this way the schisis was demarcated and then covered by scattered applications of intense photocoagulation. Treatment was considered to be complete when this pattern was achieved.
The treated eyes were re-examined after a month and then at 6-month intervals up to 6 years, and for not less than 3 years, after photocoagulation. The examination consisted of tests of visual acuity, indirect ophthalmoscopy, Goldman perimetric visual field examination, 3-mirror contact lens examination, biomicroscopy, and measurement of intraocular pressure (IOP).
Results
In Table 1 the refraction of the treated eyes is presented; most of the eyes had mild hyperopia. In Table 2 the localisation of the maximum extent of the schisis is demonstrated: all the eyes had a temporal retinoschisis, either upper or lower or both. It is worth noting that in 9 eyes the schisis occupied part of the lower nasal retina as well.
As shown in Table 3 , the schisis was demarcated and completely collapsed in 11 out of 57 eyes and demarcated and partially collapsed in 37 more eyes. The schisis did not flatten but was demarcated in the remaining 9 eyes. In none of the treated eyes was there any progression of the schisis during the followup period. It is evident that eyes in which the schisis affected only one quadrant had a higher rate of complete collapse. In none of the eyes was there a retinal detachment during the follow-up period.
The visual acuity of the treated eyes during the follow-up period is shown in Table 4 . Most of the patients kept the same visual acuity, and in those few who had a decline in their vision it was due to factors such as progression of senile cataract or change in refraction.
Choroidal haemorrhage during treatment was rare, and none of the patients had any major complication which could be attributed to the photocoagulation treatment, such as macular oedema, macular pucker, or preretinal fibrosis. 22 25 26 it is our impression, as Sullivan and von Pirquet'9 and DukeElder and Dobree' pointed out, that in most patients with retinoschisis an absolute visual field defect can be found if carefully sought. We feel that the fact that in so many patients the schisis and the visual field defect at a certain time of examination do not progress does not mean that if the retinoschisis had been diagnosed earlier it could not be prevented from progressing. We were also aware of the anxiety laid upon patients in whom retinoschisis was already diagnosed, and of the difficulties of long follow-up of some of these elderly patients. Duke-Elder' has already suggested that if the long-term results of photocoagulation are found to be good, treatment of this condition at an earlier stage may be justified.
In view of this opinion and of the lack of complications of argon laser treatment of retinoschisis reported earlier,2324 and in view of our own previous experience, we extended the indications for laser treatment beyond those previously listed by others and included the following: (a) the extension of the retinoschisis posteriorly more than 4 DD from the ora serrata when diagnosed; (b) the progression of the retinoschisis posteriorly to 4 DD or more from the ora serrata during the follow-up period. Fundus drawings correlated with landmarks, and 100 or more change in visual field defect was accepted as proving progression of the disease.
The rationale for the mode of treatment was indicated by. the nature of the disease and by its postulated pathogenesis' " and therefore included demarcation of the schisis and treatment of its entire area by strong photocoagulation application. The treatment is so perfonned in order to destroy a considerable bulk of pigment epithelium and photoreceptors and to create a finn scar reaching the inner plexiform layer, where the splitting process often takes place.
As our results show, the treatment caused either complete or partial collapse of the schisis in most of the treated eyes, it did not cause any progression of the schisis, and it caused no complication. It was much easier to evaluate the condition of the retinoschisis during the follow-up period, as the pigmented demarcating scars were easily visible on any fundus examination, even in the presence of moderately progressive cataract. There was also less need to rely on fundus drawings and on patients' co-operation during successive visual field tests, which are subject to wide variations even in intelligent patients.'0 In elderly patients, in whom lens opacity progresses, it often also becomes difficult to assess over the years whether there are holes in the outer or in both retinal layers, and whether a localised true retinal detachment develops.
Taking into consideration the results of the treatment, which is a relatively uncomplicated outpatient procedure, the lack of long-term complications, and the simplified follow-up, we suggest that laser photocoagulation treatment for retinoschisis be performed at an earlier stage than is presently accepted, according to the additional indications that we have listed. This earlier treatment may prevent an unnecessary visual field loss as well as other possible complications of long-standing retinoschisis, which, although rare, are often difficult to evaluate when cataracts have progressed and when patients become older. It can also facilitate the follow-up by better visualisation of the demarcated, pigmented photocoagulation scars. 
